Open Nav

Xcell Biosciences

  • Brian Feth, Xcell Biosciences

Raise awareness about the companies products and fundraising

  • Date:Thursday, October 18
  • Time:2:30 PM - 2:45 PM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Xcell Bio is a San Francisco-based company that builds products for immunotherapy development, enabling rapid expansion and phenotypic control of T-Cell, NK cells, and other therapeutic cell types without the need for activating agents, and can selectively enrich for subtypes of interest such as naive and memory cell populations. The company is using this proprietary capability to create a unique, protected position for improving cell therapy efficacy, safety, and persistence. The company is leveraging their platform cell control capability with primary live cell functional readouts and software for multi-parametric analysis enabling predictive and iterative therapy development.
  • Company
  • Company HQ City:San Francisco
  • Company HQ Country:United States
  • Company HQ State:California                  
  • CEO/Top Company Official:Brian Feth
  • Year Founded:2012
  • Main Therapeutic Focus:Tools/Drug Development Support Tech
  • Lead Product in Development :AVATAR Cell Control System
  • Development Phase of Primary Product:Multiple Products in Market
  • Previous and Current Investors:HBM Healthcare, Viking Global Investors, Lightspeed Venture Partners
  • Size of Last Investment Round:$6M
  • Total Amount Raised to Date, In All Rounds:$12M
Brian Feth
Xcell Biosciences